Latest News
- August 08, 2025International Publication of Phase II clinical Trial
- August 06, 2025Experience Agility-driven clinical trials with CBCC!
- July 23, 2025Discover the drive for swiftness in clinical research!
- July 16, 2025ANDA Approval Doxorubicin Hydrochloride Liposome
- July 14, 2025Accelerating Clinical Research!
May 26, 2025
ANDA application for Paclitaxel Injection (Albumin bound) supported by CBCC has received Marketing Authorization from the USFDA
